Lisha Zhou
State Key Laboratory Of Pharmaceutical Biotechnology And Nanjing Drum Tower Hospital, 163 Xianlin Avenue
Nanjing, 210023, China
Nanjing, 210023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Dietary targeting of CNBP to rein in the EREG-EGFR cascade and restore homeostasis in colitis-associated colorectal cancer.
Journal: International journal of biological sciences
Published: November 14, 2025
Tertiary lymphoid structures: The touchstone for tumor immunotherapy.
Journal: Acta pharmaceutica Sinica. B
Published: August 17, 2025
KLK1 as an Epithelial-Specific Brake Inhibits Colorectal Tumorigenesis by Suppressing B1R-Mediated Fibroblast Phenotypic Transition.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 24, 2025
Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131-TNF signaling pathway-mediated differentiation of immunosuppressive dendritic cells.
Journal: Acta pharmaceutica Sinica. B
Published: January 17, 2025
Retraction Note: Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression.
Journal: BMC cancer
Published: September 09, 2024
Targeting MAPK14 by Lobeline Upregulates Slurp1-Mediated Inhibition of Alternative Activation of TAM and Retards Colorectal Cancer Growth.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 11, 2024
Effects of different signaling pathways on odontogenic differentiation of dental pulp stem cells: a review.
Journal: Frontiers in physiology
Published: August 04, 2023
Er:YAG laser therapy in combination with GLUMA desensitizer reduces dentin hypersensitivity in children with molar-incisor hypomineralization: a randomized clinical trial.
Journal: Lasers in medical science
Published: June 12, 2023
Single-cell analyses reveal cannabidiol rewires tumor microenvironment via inhibiting alternative activation of macrophage and synergizes with anti-PD-1 in colon cancer.
Journal: Journal of pharmaceutical analysis
Published: December 19, 2022
Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation.
Journal: Journal for immunotherapy of cancer
Published: September 22, 2022
Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy.
Journal: Signal transduction and targeted therapy
Published: March 17, 2022
Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression.
Journal: BMC cancer
Published: February 16, 2022
Last Updated: 09/26/2026